Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis

<div>Evaluation of prognostic risk model for breast cancer. (a) Univariate regression analysis to evaluate prognosis models. (b) Multivariate regression analysis to evaluate prognosis models.</div>

International Journal of Genomics

fig5

Figure 5

Figure 5: Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis 